Search
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token